Table 1.
Characteristics of patients with end-stage renal disease and population control at study entry
| Variable | ESRD individuals (N = 10,908) | Population controls (N = 189,850) |
|---|---|---|
| Median years of follow-up, (interquartile range) | 2.3 (0.8–5.1) | 6.4 (2.9–10.5) |
| Age at entry (N = 200,758) | ||
| 16-49 | 2,481 (22.7%) | 39,901 (21.0%) |
| 50-64 | 3,314 (30.4%) | 57,471 (30.3%) |
| 65+ | 5,113 (46.9%) | 92,478 (48.7%) |
| Sex (N = 200,758) | ||
| Female | 4,059 (37.2%) | 71,664 (37,7%) |
| Male | 6,849 (62.8%) | 118,186 (62.3%) |
| Diabetes (N = 200,758) | ||
| No | 8,443 (77.4%) | 180,475 (95.1%) |
| Yes | 2,465 (22.6%) | 9,375 (4.9%) |
| m-CCI score (N = 200,758) | ||
| Low | 3,145 (28.8%) | 133,599 (70.4%) |
| Moderate | 4,232 (38.8%) | 43,923 (23.14%) |
| High | 3,531 (32.4%) | 12,328 (6.5%) |
| SAB event (N = 200,758) | ||
| No | 9,500 (87.1%) | 189,117 (99.6%) |
| Yes | 1,4081 (12.9%) | 733 (0.4%) |
ESRD: end-stage renal disease; m-CCI: modified Charlson Comorbidity Index; SAB: Staphylococcal aureus bacteremia.
NOTE. Baseline characteristics. Data are no. of individuals, unless otherwise indicated.
1Distribution of SAB events according to type of renal replacement therapy: renal transplantation = 23 events, hemodialysis = 1,069 events, and peritoneal dialysis = 316 events.